60
Participants
Start Date
March 31, 2009
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2015
varenicline
variable dosing schedule
placebo
placebo
Roswell Park Cancer Institute, Buffalo
Collaborators (1)
Pfizer
INDUSTRY
Roswell Park Cancer Institute
OTHER